Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing
Bloomberg Talks13 Jan 2025

Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing

Eli Lilly Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks to Bloomberg's Katie Greifeld from the JPMorgan Healthcare Conference in San Francisco.

See omnystudio.com/listener for privacy information.

Avsnitt(2646)

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-svart-marknad
rss-borsens-finest
uppgang-och-fall
avanzapodden
fill-or-kill
lastbilspodden
svd-tech-brief
rss-inga-dumma-fragor-om-pengar
bathina-en-podcast
dynastin
borsmorgon
rss-veckans-trade
rss-dagen-med-di
24fragor
rss-kort-lang-analyspodden-fran-di
rss-borslunch